Although corticosteroids were found to immediately improve best-corrected visual acuity and central macular thickness, anti–vascular endothelial growth factor (anti-VEGF) therapies had significant ...

Expert Rev Ophthalmol. 2013;8(5):475-484. Together, these preclinical data indicate that both antibody and small kinase-based VEGF/PDGF antagonists are effective in animal models of pathologic ocular ...

Alternative regimens of anti-VEGF therapy for neovascular AMD, variable treatment in particular, have become the de facto clinical practice. Their wide adoption is based on a tacit belief in their ...

Both the retina as a whole and separate retinal layers had a reduction in retinal thickness after the use of anti-vascular endothelial growth factor (VEGF) treatments. Retinal thickness was ...

Please provide your email address to receive an email when new articles are posted on . SEATTLE — In this Healio Video Perspective from the ARVO meeting, Jennifer I. Lim, MD, discusses anti-VEGF ...

A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The drug also showed potential efficacy in patients who failed to optimally ...

Sticking to the treatment schedule can be especially difficult. After you’re diagnosed, you usually need to have anti-VEGF injections about once a month, says Purnima Patel, MD, a clinical ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration -- and researchers now think they know why. Photo by Adobe Stock/HealthDay News Current treatments ...

Concerns arise as Medisep 2 excludes essential eye treatment for age-related macular degeneration, risking vision for Kerala’s pensioners.